Search results
Showing 2071 to 2085 of 8962 results
Awaiting development Reference number: GID-QS10147 Expected publication date: TBC
Awaiting development Reference number: GID-QS10149 Expected publication date: TBC
Percutaneous thrombectomy for intermediate-risk or high-risk pulmonary embolism
In development Reference number: GID-HTG10169 Expected publication date: TBC
In development Reference number: GID-TA10981 Expected publication date: TBC
Artificial intelligence (AI) technologies to help detect prostate cancer on MRI
In development Reference number: GID-HTE10089 Expected publication date: 12 November 2026
In development Reference number: GID-TA11545 Expected publication date: TBC
We are listening to your views on this HealthTech guidance. Comments close 14 April 2026.
Awaiting development Reference number: GID-HTG10536 Expected publication date: TBC
In development Reference number: GID-HTE10011 Expected publication date: TBC
Odevixibat for treating cholestasis and pruritus in Alagille Syndrome [ID6181]
In development Reference number: GID-TA11154 Expected publication date: TBC
Nedosiran treating primary hyperoxaluria type 1 in people 6 years and over [TSID11777]
Awaiting development Reference number: GID-TA11292 Expected publication date: TBC
In development Reference number: GID-QS10177 Expected publication date: TBC
Pembrolizumab with chemoradiation for untreated high-risk locally advanced cervical cancer [ID6138]
Awaiting development Reference number: GID-TA11215 Expected publication date: 07 May 2026
Awaiting development Reference number: GID-TA11200 Expected publication date: TBC
Epilepsies in children, young people and adults (extraordinary review)
In development Reference number: GID-NG10378 Expected publication date: TBC